Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 1 Lung Neoplasms 1 Carcinoma, Small Cell 1 Breast Neoplasms 1

Interventions

Fulvestrant 36 Specimen Handling 32 Letrozole 32 Paclitaxel 24 pembrolizumab 19 Carboplatin 19 Capecitabine 19 ribociclib 18 exemestane 18 palbociclib 17 Trastuzumab 17 Tamoxifen 17 Magnetic Resonance Spectroscopy 17 Anastrozole 16 Biopsy 15 trastuzumab deruxtecan 14 abemaciclib 14 pertuzumab 11 Radiotherapy 11 Cyclophosphamide 9 inavolisib 8 elacestrant 8 olaparib 7 Taxes 7 Standard of Care 7 Radiation 7 Mastectomy, Segmental 7 Goserelin 7 130-nm albumin-bound paclitaxel 7 giredestrant 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × EC regimen × 30 days × Clear all

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡